CLINICAL_TRIALS
trial_result
· 2026-07-30
Clinical Trial Results: A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease [Phase 3]
Summary
Phase 3 clinical trial results evaluating ustekinumab in pediatric patients with moderately to severely active Crohn's disease have been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Crohn Disease | Phase 3 | Status: COMPLETED | Results posted: 2026-07-30